维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Abletshauser"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment 显示文摘	Riegger G Abletshauser C Ludwig M	1999	Atherosclerosis1999，144，1：	1
2	Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension显示文摘	Hanefeld M Abletshauser C	2001	J Int Med Res2001，29，4：	1
3	The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment显示文摘	Riegger G Abletshauser C Ludwig M	1999	Atherosclerosis1999，144，1：	1
4	Fluvastatin slow-release lowers PAF-AH activity:a placebo controlled trial in patients with type 2 diabetes显示文摘	Winkler K Abletshauser C Friedrich I		0，，03：	1
5	Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia显示文摘	Haak E Abletshauser C Weber S	2001	Atherosclerosis2001，155，2：	1
6	Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients:morning administration is equivalent to evening administration显示文摘	SCHARNAGL H VOGEL M ABLETSHAUSER C	2006	Cardiology2006，106，4：	1
7	Effect of the angiotensin IIreceptor antagonist valsartan on lipid profile and glucosemetabolism in patients with hypertension 显示文摘	Hanefeld M Abletshauser C	2001	J Int MedRes2001，29，4：	1
8	Reduction of platelet activity markers in typeⅡhypercholesterolemic patients by a HMG-CoA reductase inhibitor显示文摘	Huhle G Abletshauser C Mayer N	2008	Thromb Res2008，95，5：	1
9	Effect of the angiotensin receptor blocker valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease显示文摘	Higuchi T Abletshauser C Nekolla SG	2007	Microcirculation2007，27，1：	1
10	The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment 显示文摘	Riegger G Abletshauser C Ludwig M	1999	Atherosclerosis1999，144，1：	1
11	Effect of the angiotensin II recept or antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension显示文摘	Hanefeld M Abletshauser C	2001	J Int Med Res2001，29，4：	1
12	Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity:a placebo-controlled trial in patients with type 2 diabetes显示文摘	Winkler K Abletshauser C Friedrich I	2004	J Clin Endocrinol Metab2004，89，3：	1
13	The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment显示文摘	Riegger G Abletshauser C Ludwig M		0，，01：	1
14	Effect of the angiotensin receptor blocker Valsartan on coronary mierovascular flow reserve in moderately hypertensive patients with stable coronary artery disease 显示文摘	HIGUCHI T ABLETSHAUSER C NEKOLLA S G	2007	Microcirculation2007，14，8：	1
15	Effects of angiotensin 11receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension显示文摘	Abletshauser C	2001	J Int Med Res2001，29，4：	1
16	Fluvastatin slow-release lowers plateletactivating factor acetylhydrolase: A placebo-controlled trial in patients with type 2 diabetes 显示文摘	Winkler K Abletshauser C Friedrich I	2004	J Clin Endocrin Metab2004，89，：	1
17	Effects of the angiotensin Ⅱreceptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension显示文摘	Hanefeld M Abletshauser C	2001	J int Med Res2001，，29：	1
18	The lipoprotein and coronary atheroselerosis study(LCAS)显示文摘	Huhle G Abletshauser C Mayer N	1997	Am J Cardiol1997，80，3：	1
19	Fluvastatin lowers atherogenie dLDL in postmenopausal women with the atherogenie lipoprotein phenotype 显示文摘	MARZ W SCHARNAGL H ABLETSHAUSER C	2001	Cireulation2001，103，：	1
20	The renal safety profile of fluvastatin: results of a pooled analysis 显示文摘	HoldaasH Wanner C Abletshauser C	2006	Ren Fail2006，28，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示